← FDA Drug Approvals (Drugs@FDA)

SYMBYAX

NDA · New Drug Application · Sponsor: LILLY · Approved 2003-12-24

Drug application

FDA Application #

NDA021520

Application type

New Drug Application

Brand name

SYMBYAX

Generic name

Fluoxetine Hydrochloride

Active ingredients

FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

LILLY

First approval

2003-12-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown